(E)-2-Methoxy-4-(3-(4-methoxyphenyl) prop-1-en-1-yl)
phenol (
MMPP), a new (E)-2,4-bis(p-hydroxyphenyl)-2 - butenal derivative, reportedly has
therapeutic effects such as anti-arthritic properties. Although previous studies showed that
MMPP has anti-arthritic effects on
rheumatoid arthritis (RA), the anti-
inflammation mechanism of
MMPP remains unclear. In this study,
phorbol-12-myristate 13-acetate (PMA) was used as an inflammatory stimulus to evaluate the detailed mechanism of the
MMPP-mediated anti-inflammatory effect in human monocytic THP-1 cells. We investigated the effects of
MMPP on
inflammation-related pathways including
protein kinase Cδ (PKCδ),
mitogen-activated protein kinase, and
activator protein-1 (AP-1). PMA induced the translocation of
PKCs from the cytosol to the membrane and phosphorylated JNK.
MMPP inhibited PMA-induced membrane translocation of PKCδ, phosphorylation of JNK, and nuclear translocation of
AP-1, resulting in downregulation of
cyclooxygenase-2 and
chemokine ligand 5 production. These findings indicate that
MMPP inhibits inflammatory responses in THP-1 cells by mitigating PMA-induced activation of PKCδ and JNK and nuclear translocation of
AP-1. Therefore,
MMPP may be useful as an anti-inflammatory drug.